Results of MELD-ATG and Ver-A-T1D clinical trials at EASD 19 Sept 2025!
We are excited to announce that results of both MELD-ATG and Ver-A-T1D clinical trials, which were conducted under INNODIA and INNODIA HARVEST projects, will be presented at the EASD congress in Vienna in an Early Bird slot ‘Towards arresting type 1 diabetes: breaking results of the MELD-ATG trial and Ver-A-T1D trial using the INNODIA masterprotocol’, on Friday 19th September 2025 at 7.15am.
If you are participating to EASD congress, don’t miss this opportunity and join this unique event. Click the button below for more details on the session.
The end of INNODIA and beginning of INNODIA.org
About INNODIA
For people with type 1 diabetes
Participant Spotlight
For people with an increased T1D risk
For researchers
